After Hours Summary: SMAR -5.6%, GWRE -1.3% lower on earnings; CURV +4.7% higher on earnings; NVAX +13.5% as FDA advisory committee recommends EUA for its COVID-19 vaccineAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: CURV +4.7%, VRNT +1.3%, CASY +0.5% (also increases dividend)
Companies trading higher in after hours in reaction to news: DBVT +37.9% (positive topline results from Phase 3 EPITOPE Trial), NVAX +13.5% (FDA advisory committee recommends EUA for its COVID-19 vaccine), PNTG +5.3% (names new CEO), DOCU +4.4% (expands partnership with MSFT to accelerate anywhere work), EIGR +2.1% (enters into $75 mln term loan agreement with Innovatus), AWK +2% (acquires Village of Hardin water and wastewater systems), CPLP +0.3% (acquries carriers), NVRO +0.2% (says clinical data reinforces benefits of Nevro's HFX 10 kHz Therapy), PAYC +0.1% (increases and extends stock repurchase plan), SF +0.1% (to acquire ACXIT Capital Partners)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: SMAR -5.6%, OI -3.1%, GWRE -1.3%
Companies trading lower in after hours in reaction to news: CCSI -3.3% (files for 2 mln share offering by selling shareholders), GT -1.9% (recalling 170,000 tires produced between 1996-2003, according to the NHTSA), GENI -0.9% (stock offering), SNY -0.7% (FDA approves Dupixent for children with moderate-to-severe atopic dermatitis), INSW -0.1% (INSW completes transaction to sell 50% stake in FSO vessels to EURN; also increases dividend)